Recent Updates
Recently added Catalysts
IART Negative Sentiment Score: 25/100

INTEGRA LIFESCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Integra LifeSciences Holdings Corporation - IART

Key Takeaway: Integra LifeSciences Holdings Corporation is facing a class action lawsuit filed by investors who purchased shares between March 11, 2019 and May 22, 2023. The lawsuit alleges that the company failed to disclose material information, particularly related to a significant recall of medical devices. Following the recall announcement and a lowered revenue guidance, Integra's shares dropped by 20%, resulting in substantial financial losses for investors. The deadline to file lead plaintiff applications in this class action lawsuit is November 13, 2023.

Market Sentiment Analysis

CONCERNS & RISKS

  • Integra LifeSciences is facing a class action lawsuit for failing to disclose material information.
  • The company recalled all medical device products from its Boston Facility due to manufacturing issues.
  • Shares of Integra fell by 20% after the recall announcement, indicating a loss of investor confidence.
  • A significant impairment charge of $22 million is expected due to inventory write-off.

Full Press Release Details

NEW ORLEANS, Nov. 07, 2023 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 13, 2023 to file lead plaintiff applications in a securities class action lawsuit against Integra LifeSciences Holdings Corporation (NasdaqGS: IART), if they purchased the Company’s shares between March 11, 2019 and May 22, 2023, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of New Jersey.
Integra investors should visit us at https://claimsfiler.com/cases/nasdaq-iart/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
Integra and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On May 23, 2023, the Company disclosed that it was recalling all medical device products made at its Boston Facility between March 1, 2018 and May 22, 2023 due to a deviation from good manufacturing practices in testing for bacterial endotoxin and the release of products with higher levels of endotoxins, as well as an extended halt on production. As a result, the Company lowered its 2Q 2023 revenue guidance by 6% and adjusted earnings per diluted share by 26% and disclosed an expected $22 million impairment charge due to the inventory write-off.
On this news, shares of Integra plummeted $10.24 per share, or 20%, from a closing price of $50.72 per share on May 22, 2023, to a closing price of $40.48 per share on May 23, 2023.
The case is Pembroke Pines Firefighters & Police Officers Pension Fund v. Integra LifeSciences Holdings Corporation, No. 23-cv-20321.
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.
To learn more about ClaimsFiler, visit www.claimsfiler.com.

Tags

Frequently Asked Questions

What is the deadline to file a lead plaintiff application?

Investors must file lead plaintiff applications by November 13, 2023.

What is the Class Period for the Integra lawsuit?

The Class Period for the Integra lawsuit is from March 11, 2019 to May 22, 2023.

Why are executives of Integra being sued?

Executives are charged with failing to disclose material information, violating federal laws.

How did Integra's stock react to the May 2023 news?

Shares fell by 20%, dropping from $50.72 to $40.48 in one day.

Where can I find more information about the lawsuit?

Visit ClaimsFiler at https://claimsfiler.com/cases/nasdaq-iart/ for details.

Last updated: Nov 8, 2023